Abiopharma

New Form 6-K - Biophytis SA Filed: 2025-08-28 AccNo: 0001104659-25-084446 Size: 27 KB

New Form 8-K - Fulcrum Therapeutics, Inc. Filed: 2025-08-28 AccNo: 0001193125-25-190746 Size: 15 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

PMGC Holdings Inc. Announces Anticipated Reverse Stock Split

New Form 144 - PTC THERAPEUTICS, INC. Filed: 2025-08-28 AccNo: 0001959173-25-005591 Size: 4 KB

SciSparc: AutoMax’s Shareholders Approve Merger with SciSparc

TNF Pharmaceuticals Announces Reverse Stock Split For Nasdaq Listing Compliance

New Form 6-K - CytoMed Therapeutics Ltd Filed: 2025-08-28 AccNo: 0001641172-25-025761 Size: 39 KB

Tectonic Therapeutic to Participate in September Investor Conferences

Masimo - Masimo to Present in the Wells Fargo Healthcare Conference

Codexis to Participate in Cantor Global Healthcare Conference

Update on recent acquisition - CytoMed Therapeutics expands into auto-immune diseases building on its recent cord blood bank acquisition

Oncotelic Therapeutics Showcases Robust Pipeline and Founder’s Broad Intellectual Property Contributions to Biopharma Industry

New Form 6-K - Can-Fite BioPharma Ltd. Filed: 2025-08-28 AccNo: 0001213900-25-081407 Size: 3 MB

Can-Fite Reports H1 2025 Financial Results and Clinical Update

Can-Fite Reports H1 2025 Financial Results and Clinical Update